Oxygen utilization during and after isolated limb perfusion with rhTNFα and melphalan
暂无分享,去创建一个
[1] B. Vrouenraets,et al. Severe acute regional toxicity after normothermic or 'mild' hyperthermic isolated limb perfusion with melphalan for melanoma , 1995, Melanoma research.
[2] R. Chioléro,et al. Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs. , 1995, Chest.
[3] A. Eggermont,et al. Harly endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high‐dose tumour necrosis factor alpha (rTNFα) , 1994 .
[4] G. Sigurdsson,et al. Anesthesiologists' management of isolated limb perfusion with "high-dose" tumor necrosis factor alpha. , 1993, Anesthesiology.
[5] M. Gore,et al. Hemodynamic changes and circulating recombinant tumor necrosis factor-alpha concentrations in a patient undergoing isolated limb perfusion. , 1993, Critical care medicine.
[6] E. V. van Slooten,et al. Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. , 1982, European journal of cancer & clinical oncology.